User:Goorgle/Books/Cancer Wiki 101
The Wikimedia Foundation's book rendering service has been withdrawn. Please upload your Wikipedia book to one of the external rendering services. |
You can still create and edit a book design using the Book Creator and upload it to an external rendering service:
|
This user book is a user-generated collection of Wikipedia articles that can be easily saved, rendered electronically, and ordered as a printed book. If you are the creator of this book and need help, see Help:Books (general tips) and WikiProject Wikipedia-Books (questions and assistance). Edit this book: Book Creator · Wikitext Order a printed copy from: PediaPress [ About ] [ Advanced ] [ FAQ ] [ Feedback ] [ Help ] [ WikiProject ] [ Recent Changes ] |
Cancer Wiki 101[edit]
Cancer Wiki 101[edit]
- 1 Month 2 Live
- 12-O-Tetradecanoylphorbol-13-acetate
- 14-Norpseurotin A
- 2-Acetylaminofluorene
- 21st Century Cancer Access to Life-Saving Early detection, Research and Treatment (ALERT) Act
- 3-Nitrobenzanthrone
- 4,4'-Thiodianiline
- 4-Chloro-o-toluidine
- 4-Methylimidazole
- 4-Nitroquinoline 1-oxide
- 7,12-Dimethylbenz(a)anthracene
- A Summer to Die
- ABCD rating
- Abscopal effect
- Acetoxyacetylaminofluorene
- Action study
- Active hexose correlated compound
- Active surveillance
- Adductomics
- Adenocarcinoma
- Adjuvant therapy
- Agent Orange
- Agent study
- AJCC staging system
- Alcohol and breast cancer
- Alcohol and cancer
- ALECSAT
- Alternative cancer treatments
- American Cancer Society
- American Institute for Cancer Research
- Americium
- Americium-243
- Amsterdam criteria
- Anaplasia
- Aneugen
- Anil Potti
- Ann Arbor staging
- Anti-malignin antibody
- Antibody
- Anticancer genes
- Antineoplastic resistance
- Arbiskov cell
- Armitage–Doll multistage model of carcinogenesis
- Aromatic hydrocarbon
- Arsenic tribromide
- Asbestos
- Asbestos and the law
- Atrasentan
- Atypia
- Autologous immune enhancement therapy
- Autologous patient specific tumor antigen response
- Autologous tumor cell
- Automated tissue image analysis
- Autophagic tumor stroma model of cancer
- AYA Cancer
- Azoxymethane
- B symptoms
- Basal-cell carcinoma
- Bcl-xL
- Beckman Research Institute
- Before I Die
- Benign prostatic hyperplasia
- Benign tumor
- Benignity
- Benzopyrene
- Binucleated cells
- Biochemical recurrence
- Biological clock (aging)
- Bionovo
- Biopsy
- BioTime
- Bleomycin
- Bloating
- BMS-906024
- Bolus (radiation therapy)
- Bone Cancer Research Trust
- Bone marrow suppression
- Breslow's depth
- Bromate
- Bruce Ponder
- C-Met inhibitors
- CaBIG
- CaGrid
- Caisis
- Calcium arsenate
- Calicheamicin
- Cancer
- Cancer Act 1939
- Cancer and nausea
- Cancer bacteria
- Cancer biomarkers
- Cancer cell
- Cancer dormancy
- Cancer Drugs Fund
- Cancer immunology
- Cancer immunoprevention
- Cancer immunotherapy
- Cancer pain
- Cancer registry
- Cancer research
- Cancer signs and symptoms
- Cancer slope factor
- Cancer staging
- Cancer stem cell
- Cancer survival rates
- Cancer survivor
- Cancer syndrome
- Cancer systems biology
- Cancer Vixen: A True Story
- Cancerous micronuclei
- CancerResource
- Canine cancer detection
- Carcinogen
- Carcinogenesis
- Carcinoma
- Carcinoma in situ
- Carcinosis
- CaSNP
- CD137
- CD47
- Cervical cancer gene database
- Cervical cancer staging
- Chemosensitivity assay
- Chemotherapy
- Chemotherapy-induced acral erythema
- Chemotherapy-induced nausea and vomiting
- Chemotherapy-induced peripheral neuropathy
- Childhood cancer
- Chromatin remodeling
- Circulating tumor cell
- City of Hope National Medical Center
- Clark's level
- Clonally transmissible cancer
- Co-carcinogen
- Colon cancer staging
- Common Terminology Criteria for Adverse Events
- Contact normalization
- Corpora amylacea
- COSMIC cancer database
- Cruciferous vegetables
- Cucurbitacin D
- Cystoprostatectomy
- Cysview
- Dabrafenib
- David H. Koch Institute for Integrative Cancer Research
- Delaney clause
- Desmoplasia
- Detoxification (alternative medicine)
- Deuterium-depleted water
- Diepoxybutane
- Diet and cancer
- Digital Mammographic Imaging Screening Trial
- Discovery and development of antiandrogens
- Discovery and development of mTOR inhibitors
- Distress in cancer caregiving
- DNA adduct
- DNA repair-deficiency disorder
- Docrates Cancer Center
- Donald Engelman
- Donor lymphocyte infusion
- Dose profile
- Dose verification system
- Double minute
- Dressed to Kill (book)
- DU145
- Duclauxin
- Dynemicin A
- Dysplasia
- E-Foundation for Cancer Research
- EBC-46
- Edward J. Benz, Jr.
- Ejaculation
- Electrochemotherapy
- Enediyne
- Enhanced permeability and retention effect
- Epidemiology of cancer
- Epididymis
- Epigenetics
- Epithelial–mesenchymal transition
- Epithelium
- Eppley Institute for Research in Cancer and Allied Diseases
- Esperamicin
- Ethionine
- Exocrine gland
- Experimental cancer treatment
- Febrile neutropenia
- Flavagline
- Flexner–Wintersteiner rosette
- Food, Nutrition, Physical Activity and the Prevention of Cancer: a Global Perspective
- Fractional kill
- Frederic E. Mohs
- Fungating lesion
- Furylfuramide
- Gene expression profiling in cancer
- Genetics of cancer
- Genotoxicity
- Geriatric oncology
- Geron Corporation
- Gland
- Glandular and epithelial neoplasm
- Gleason Grading System
- Glucocorticoid
- Glycoprotein 100
- Gold nanobeacons
- Grading (tumors)
- Granisetron
- Growth inhibition
- Hazardous drugs
- Health effects of sun exposure
- Health effects of tobacco
- Hematological malignancy
- Hernandezine
- Heterocyclic amine
- Heterocyclic amine formation in meat
- Hexvix
- High-dose chemotherapy and bone marrow transplant
- High-grade prostatic intraepithelial neoplasia
- Histopathology
- History of cancer
- Homeobox protein NANOG
- Homer-Wright rosette
- Hsp90 inhibitor
- HT1080
- Human male reproductive system
- Human papillomavirus
- Hydroxyacetylaminofluorene
- Hypercalcaemia
- Imaging agent
- Immunoglobulin superfamily
- Immunotherapy
- Incidentaloma
- Index of oncology articles
- Indole-3-carbinol
- Infectious causes of cancer
- Instruments used in oncology
- Interleukin 2
- Interleukin 7
- Interleukin-2 immunotherapy
- International Myeloma Foundation
- International Prognostic Index
- Intravasation
- Invasion of the Prostate Snatchers
- Irell & Manella Graduate School of Biological Sciences
- Isothiocyanate
- Janus Experiments
- Jonsson Comprehensive Cancer Center
- Juvenile active ossifying fibroma
- Kataegis
- Kathy Giusti
- Kepone
- Knudson hypothesis
- Lactate shuttle
- Laparoscopic radical prostatectomy
- Large cell
- Lavendamycin
- Learning problems in childhood cancer
- Length time bias
- Leucoerythroblastic
- Leucosis
- Leukemia inhibitory factor
- Lewis lung carcinoma
- Linear no-threshold model
- List of IARC Group 1 carcinogens
- List of IARC Group 2A carcinogens
- List of IARC Group 2B carcinogens
- LNCaP
- Lovaxin C
- Lunasin
- Lycoctonine
- M1G
- Malignancy
- Malignant transformation
- MALOVA
- Management of cancer
- Management of prostate cancer
- Mark Scholz
- Mass effect (medicine)
- Medical genetics
- Medscape
- Meigs syndrome
- Mesenchymal–epithelial transition
- Metaplasia
- Metastasis
- Methyl-n-amylnitrosamine
- Methylation specific oligonucleotide microarray
- Methylcholanthrene
- Mezerein
- Micrometastasis
- Microsatellite instability
- Microstaging
- Molecular epidemiology
- Molecular oncology
- Molecular Therapy
- Multiple Myeloma Research Consortium
- Multiple Myeloma Research Foundation
- Multipolar spindles
- My Sister's Keeper (novel)
- Myeloma protein
- Myoma
- N-Nitroso-N-methylurea
- Nanobiotix
- National Biomedical Imaging Archive
- National Cancer Intelligence Network
- National Institute of Cancer Research & Hospital
- National Institute of Health (Pakistan)
- National Institutes of Health
- Neoadjuvant therapy
- Neocarzinostatin
- Neoplasm
- Neurooncology
- NeuVax
- New Approaches to Cancer
- Nicholas Chiorazzi
- Nigro protocol
- NK-92
- Notes Left Behind
- O. Carl Simonton
- Occupational Cancer Convention, 1974
- Oncoantigen
- Oncocyte
- Oncodynamics
- Oncofertility
- Oncogene
- Oncology
- Oncology benefit management
- Oncology nursing
- Oncomir
- Oncotherm
- Oncotype DX
- Oncovirus
- Orbital lymphoma
- Orchid (charity)
- Orthopedic oncologist
- OSI-7904L
- Osteomimicry
- Pagetoid
- Palmitoyl acyltransferase
- Parathyroid hormone-related protein
- Pathological staging
- Patient trade-off
- PC3
- Percutaneous hepatic perfusion
- Performance status
- Peto's paradox
- Phorbol 12,13-dibutyrate
- Phosphaturic mesenchymal tumor
- Phosphoinositide 3-kinase
- Photocarcinogen
- Photodynamic therapy
- Physician Data Query
- Plant sources of anti-cancer agents
- Plasmonic nanoparticles
- Pluramycin A
- Plutonium
- Polycyclic aromatic hydrocarbon
- Polypeptide antibiotics
- Polyposis registries
- Polysaccharide peptide
- Port (medical)
- Positive axillary lymph node
- Precancerous condition
- Predictive marker
- Prognosis
- Proliferative index
- Prophylactic cranial irradiation
- Prosoplasia
- Prostate
- Prostate biopsy
- Prostate brachytherapy
- Prostate cancer
- Prostate cancer screening
- Prostate cancer staging
- Prostate Rectum Spacers
- Prostate saturation biopsy
- Prostate-specific antigen
- Prostatectomy
- Prostatic acid phosphatase
- Prostatic ducts
- Prostatic sinus
- Prostatic stent
- Prostatic urethra
- Prostatic utricle
- Prostatic venous plexus
- Provascular anticancer therapy
- Psycho-oncology
- Ptaquiloside
- PTK2
- Quackwatch
- Radiation oncologist
- Radiation-induced thyroiditis
- Radical perineal prostatectomy
- Radical retropubic prostatectomy
- Radiosensitivity
- Radon
- Ralph Bates Pancreatic Cancer Research Fund
- Randy Shaver Cancer Research and Community Fund
- Re-Mission
- Reactive oxygen species
- Rectoprostatic fascia
- Replication error phenotype
- Rescue fusion hybridization
- Response Evaluation Criteria in Solid Tumors
- Retigeric acid B
- RNAi-Based Identification System and interference of Specific Cancer Cells
- Ruthenium anti-cancer drugs
- Sarcoma
- Scientific Review of Alternative Medicine
- Sentinel lymph node
- Sex organ
- SH-SY5Y
- Sister Mary Joseph nodule
- Skin Cancer: Recognition and Management
- Small-cell carcinoma
- Smooth muscle tumour
- Somatic evolution in cancer
- Spiculated mass
- Spinal cord compression
- Spontaneous remission
- Steganacin
- Sterile talc powder
- Stitches (book)
- Sulforaphane
- Sunesis Pharmaceuticals
- Surveillance, Epidemiology, and End Results
- Survivin
- Talimogene laherparepvec
- Targeted molecular therapy for neuroblastoma
- Targetoid
- Tasquinimod
- Terpestacin
- Testicle
- Testicular cancer
- Tetracycline
- The Cancer Genome Atlas
- The Cancer Journals
- The Cancer Survivors Club
- The Christmas Tree (novel)
- The Council of Dads
- The Emperor of All Maladies: A Biography of Cancer
- The Fault in Our Stars
- The Hallmarks of Cancer
- The Immortal Life of Henrietta Lacks
- The Last Lecture
- The Prostate
- The Test of My Life: From Cricket to Cancer and Back
- Theaflavin
- Theaflavin digallate
- Thorium
- Tn antigen
- TNM staging system
- Tobacco-specific nitrosamines
- TopoTarget
- Trametinib
- Transitional cell carcinoma
- Transurethral incision of the prostate
- Transurethral resection of the prostate
- Treatment and prognosis of renal cell carcinoma
- Tubuloalveolar
- Tumor antigen
- Tumor board review
- Tumor hypoxia
- Tumor initiation
- Tumor lysis syndrome
- Tumor M2-PK
- Tumor metabolome
- Tumor microenvironment
- Tumor progression
- Tumor promotion
- Tumor reversion
- Tumor suppressor gene
- Tumor Treating Fields
- Tumor-infiltrating lymphocytes
- Tumour heterogeneity
- Uganda Program on Cancer and Infectious Diseases
- Ultraviolet light and cancer
- Verocay body
- Veterinary oncology
- Vindoline
- Virtual karyotype
- War on Cancer
- Warburg effect
- Warburg hypothesis
- Ways to Live Forever
- WebMD
- Work Capability Assessment
- World Cancer Research Fund
- World Cancer Research Fund UK
- Yorkshire Cancer Research
- ZNF202